{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:27:00Z","timestamp":1794274020088,"version":"4.9.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Palliat Care"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Huntington\u2019s Disease (HD) is an incurable, progressive neuro-degenerative disease. For patients with HD access to palliative care services is limited, with dedicated Neuro-Palliative Care Services rare in Australia. We discuss the experiences of and benefits to a patient with late-stage HD admitted to our Neuro-Palliative Care service.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>We present the case of a patient with a 16-year history of HD from time of initial genetic testing to admission to our Neuro-Palliative Care service with late-stage disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Given the prolonged, fluctuating and heterogenous HD trajectory, measures need to be implemented to improve earlier access to multi-specialty integrative palliative care services. Given the good outcomes of our case, we strongly advocate for the role of specialised Neuro-Palliative Care services to bridge the gap between clinical need and accessibility.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12904-021-00744-z","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T19:02:47Z","timestamp":1617303767000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["An Australian Neuro-Palliative perspective on Huntington's disease: a case report"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6092-725X","authenticated-orcid":false,"given":"Rajvi","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah CM","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupert B","family":"Strasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"key":"744_CR1","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s00415-017-8677-7","volume":"265","author":"NE Carlozzi","year":"2018","unstructured":"Carlozzi NE, Hahn EA, Frank SA, Perlmutter JS, Downing ND, McCormack MK, et al. A new measure for end of life planning, preparation, and preferences in Huntington disease: HDQLIFE end of life planning. J Neurol. 2018;265:98\u2013107.","journal-title":"J Neurol"},{"key":"744_CR2","first-page":"1","volume":"7","author":"CG Tarolli","year":"2017","unstructured":"Tarolli CG, Chesire AM, Biglan KM. Palliative care in huntington disease: Personal reflections and a review of the literature. Tremor Other Hyperkinet Mov. 2017;7:1\u20138.","journal-title":"Tremor Other Hyperkinet Mov"},{"key":"744_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2217\/fnl.09.78","volume":"5","author":"JS Paulsen","year":"2010","unstructured":"Paulsen JS. Early detection of Huntington\u2019s disease. Future Neurol. 2010;5:85\u2013104.","journal-title":"Future Neurol"},{"key":"744_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/0269216315619129","volume":"30","author":"S Booth","year":"2016","unstructured":"Booth S, Fallon M, Hollis G. Rhetoric and reality - Matching palliative care services to meet the needs of patients of all ages, with any diagnosis. Palliat Med. 2016;30:3\u20135.","journal-title":"Palliat Med"},{"key":"744_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.12968\/ijpn.2007.13.3.23274","volume":"13","author":"E Travers","year":"2007","unstructured":"Travers E, Jones K, Nichol J. Palliative care provision in Huntington\u2019s disease. Int J Palliat Nurs. 2007;13:125\u201330.","journal-title":"Int J Palliat Nurs"},{"key":"744_CR6","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1001\/jamaneurol.2013.123","volume":"70","author":"ER Dorsey","year":"2013","unstructured":"Dorsey ER, Beck CA, Darwin K, Nichols P, Brocht AFD, Biglan KM, et al. Natural history of Huntington disease. JAMA Neurol. 2013;70:1520\u201330.","journal-title":"JAMA Neurol"},{"key":"744_CR7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1602\/neurorx.1.2.255","volume":"1","author":"RH Myers","year":"2004","unstructured":"Myers RH. Huntington\u2019s Disease Genetics. NeuroRx. 2004;1:255\u201362. doi:https:\/\/doi.org\/10.1602\/neurorx.1.2.255.","journal-title":"NeuroRx"},{"key":"744_CR8","doi-asserted-by":"publisher","unstructured":"Reiner A, Dragatsis I, Dietrich P. Genetics and neuropathology of huntington\u2019s disease. In: International Review of Neurobiology. Academic Press Inc.; 2011. p.\u00a0325\u201372. doi:https:\/\/doi.org\/10.1016\/B978-0-12-381328-2.00014-6.","DOI":"10.1016\/B978-0-12-381328-2.00014-6"},{"key":"744_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.12968\/bjon.1997.6.2.83","volume":"6","author":"H Skirton","year":"1997","unstructured":"Skirton H, Glendinning N. Using research to develop care for patients with Huntington\u2019s disease. Br J Nurs. 1997;6:83\u201390.","journal-title":"Br J Nurs"},{"key":"744_CR10","doi-asserted-by":"crossref","unstructured":"Macleod AD, Jury MA, Anderson T. The (Palliative) care of Huntington\u2019s disease. 2017.","DOI":"10.1080\/09699260.2017.1337608"},{"key":"744_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1750-1172-5-40","volume":"5","author":"RAC Roos","year":"2010","unstructured":"Roos RAC. Huntington\u2019s disease: A clinical review. Orphanet J Rare Dis. 2010;5:40. doi:https:\/\/doi.org\/10.1186\/1750-1172-5-40.","journal-title":"Orphanet J Rare Dis"},{"key":"744_CR12","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3233\/JHD-160192","volume":"5","author":"JC Frich","year":"2016","unstructured":"Frich JC, Rae D, Roxburgh R, Miedzybrodzka ZH, Edmondson M, Pope EB, et al. Health Care Delivery Practices in Huntington\u2019s Disease Specialty Clinics: An International Survey. J Huntingtons Dis. 2016;5:207\u201313. doi:https:\/\/doi.org\/10.3233\/JHD-160192.","journal-title":"J Huntingtons Dis"},{"key":"744_CR13","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13023-015-0324-8","volume":"10","author":"MR van Walsem","year":"2015","unstructured":"van Walsem MR, Howe EI, Iversen K, Frich JC, Andelic N. Unmet needs for healthcare and social support services in patients with Huntington\u2019s disease: A cross-sectional population-based study. Orphanet J Rare Dis. 2015;10:124. doi:https:\/\/doi.org\/10.1186\/s13023-015-0324-8.","journal-title":"Orphanet J Rare Dis"},{"key":"744_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2217\/nmt.11.81","volume":"2","author":"C Cook","year":"2012","unstructured":"Cook C, Page K, Wagstaff A, Simpson SA, Rae D. Development of guidelines for occupational therapy in Huntington\u2019s disease. Neurodegener Dis Manag. 2012;2:79\u201387. doi:https:\/\/doi.org\/10.2217\/nmt.11.81.","journal-title":"Neurodegener Dis Manag"},{"key":"744_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2217\/nmt.11.78","volume":"2","author":"A Hamilton","year":"2012","unstructured":"Hamilton A, Ferm U, Heemskerk A-W, Twiston-Davies R, Matheson KY, Simpson SA, et al. Management of speech, language and communication difficulties in Huntington\u2019s disease. Neurodegener Dis Manag. 2012;2:67\u201377. doi:https:\/\/doi.org\/10.2217\/nmt.11.78.","journal-title":"Neurodegener Dis Manag"},{"key":"744_CR16","doi-asserted-by":"publisher","unstructured":"Piira A, van Walsem MR, Mikalsen G, \u00d8ie L, Frich JC, Knutsen S. Effects of a Two-Year Intensive Multidisciplinary Rehabilitation Program for Patients with Huntington\u2019s Disease: a Prospective Intervention Study. PLoS Curr. 2014;6 SEP. doi:https:\/\/doi.org\/10.1371\/currents.hd.2c56ceef7f9f8e239a59ecf2d94cddac.","DOI":"10.1371\/currents.hd.2c56ceef7f9f8e239a59ecf2d94cddac"},{"key":"744_CR17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/NPT.0000000000000016","volume":"37","author":"M Busse","year":"2013","unstructured":"Busse M, Quinn L, Debono K, Jones K, Collett J, Playle R, et al. A randomized feasibility study of a 12-week community-based exercise program for people with Huntington\u2019s disease. J Neurol Phys Ther. 2013;37:149\u201358. doi:https:\/\/doi.org\/10.1097\/NPT.0000000000000016.","journal-title":"J Neurol Phys Ther"},{"key":"744_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1442-2018.2004.00183.x","volume":"6","author":"S Dwason","year":"2004","unstructured":"Dwason S, Kristjanson L, Toye CM, Flett P. Living with Huntington\u2019s disease: Need for supportive care. Nurs Health Sci. 2004;6:123\u201330.","journal-title":"Nurs Health Sci"},{"key":"744_CR19","doi-asserted-by":"crossref","unstructured":"Nance M, Paulsen JS, Rosenblatt A, Wheelock V. A Physician\u2019s Guide to the Management of Huntington \u2019 s Disease. 3rd. Huntington\u2019s Disease Society of America. 2011;:140.","DOI":"10.1016\/B978-0-12-801893-4.00001-8"},{"key":"744_CR20","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1002\/mds.20589","volume":"20","author":"RM Dubinsky","year":"2005","unstructured":"Dubinsky RM. No going home for hospitalized Huntington\u2019s disease patients. Mov Disord. 2005;20:1316\u201322. doi:https:\/\/doi.org\/10.1002\/mds.20589.","journal-title":"Mov Disord"},{"key":"744_CR21","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1002\/mdc3.12502","volume":"4","author":"FB Rodrigues","year":"2017","unstructured":"Rodrigues FB, Abreu D, Dam\u00e1sio J, Goncalves N, Correia-Guedes L, Coelho M, et al. Survival, Mortality, Causes and Places of Death in a European Huntington\u2019s Disease Prospective Cohort. Mov Disord Clin Pract. 2017;4:737\u201342.","journal-title":"Mov Disord Clin Pract"},{"key":"744_CR22","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0733-8619(05)70050-5","volume":"19","author":"CB Moskowitz","year":"2001","unstructured":"Moskowitz CB, Marder K. Palliative care for people with late-stage Huntington\u2019s disease. Neurol Clin. 2001;19:849\u201365.","journal-title":"Neurol Clin"},{"key":"744_CR23","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1177\/1049909117708195","volume":"35","author":"NR Downing","year":"2018","unstructured":"Downing NR, Goodnight S, Chae S, Perlmutter JS, McCormack M, Hahn E, et al. Factors Associated With End-of-Life Planning in Huntington Disease. Am J Hosp Palliat Care. 2018;35:440\u20137.","journal-title":"Am J Hosp Palliat Care"},{"key":"744_CR24","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12904-016-0119-2","volume":"15","author":"L Rosenwax","year":"2016","unstructured":"Rosenwax L, Spilsbury K, McNamara BA, Semmens JB. A retrospective population based cohort study of access to specialist palliative care in the last year of life: Who is still missing out a decade on? BMC Palliat Care. 2016;15:46.","journal-title":"BMC Palliat Care"},{"key":"744_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1891\/1521-0987.9.2.75","volume":"9","author":"J Klager","year":"2008","unstructured":"Klager J, Duckett A, Sandler S, Moskowitz C. Huntington\u2019s disease: A caring approach to the end of life. Care Manag J. 2008;9:75\u201381.","journal-title":"Care Manag J"},{"key":"744_CR26","unstructured":"Dubinsky R. Lifting the Veil of Huntington\u2019s Disease Overview of Promoting Excellence Workgroups. 2015."},{"key":"744_CR27","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1001\/archneur.1991.00530200036015","volume":"48","author":"RH Myers","year":"1991","unstructured":"Myers RH, Sax DS, Kiely DK, Pettengill FK, Koroshetz WJ, Mastromauro C, et al. Factors Associated With Slow Progression in Huntington\u2019s Disease. Arch Neurol. 1991;48:800\u20134.","journal-title":"Arch Neurol"},{"key":"744_CR28","unstructured":"Foley KM, Caver AC. Palliative care and neurology: Time for a paradigm shift. Neurology. 2014;83(6):561-7. 2001;19:789\u201399."},{"key":"744_CR29","unstructured":"Australian Commission on Safety and Quality in Health Care. National Consensus Statement: Essential elements for safe and high-quality end-of-life care. 2015. http:\/\/www.safetyandquality.gov.au\/wp-content\/uploads\/2015\/05\/National-Consensus-Statement-Essential-Elements-forsafe-high-quality-end-of-life-care.pdf. Accessed 6 Mar 2020."},{"key":"744_CR30","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1007\/s00415-014-7479-4","volume":"261","author":"SJ Booij","year":"2014","unstructured":"Booij SJ, Tibben A, Engberts DP, Marinus J, Roos RAC. Thinking about the end of life: a common issue for patients with Huntington\u2019s disease. J Neurol. 2014;261:2184\u201391.","journal-title":"J Neurol"},{"key":"744_CR31","doi-asserted-by":"crossref","first-page":"e018024","DOI":"10.1136\/bmjopen-2017-018024","volume":"7","author":"R Ruseckaite","year":"2017","unstructured":"Ruseckaite R, Detering KM, Evans SM, Perera V, Walker L, Sinclair C, et al. Protocol for a national prevalence study of advance care planning documentation and self-reported uptake in Australia. BMJ Open. 2017;7:e018024.","journal-title":"BMJ Open"},{"key":"744_CR32","first-page":"4","volume":"19","author":"OD Semple","year":"1995","unstructured":"Semple OD. The experiences of family members of persons with Huntington\u2019s disease. Perspectives (Gerontol Nurs Assoc (Canada)). 1995;19:4\u201310.","journal-title":"Perspectives (Gerontol Nurs Assoc (Canada))"},{"key":"744_CR33","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3233\/JHD-130060","volume":"2","author":"SJ Booij","year":"2013","unstructured":"Booij SJ, Verena R. Euthanasia and Advance Directives in Huntington \u2019 s Disease: Qualitative Analysis of Interviews with Patients. J Huntingtons Dis. 2013;2:323\u201330.","journal-title":"J Huntingtons Dis"}],"container-title":["BMC Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-021-00744-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12904-021-00744-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-021-00744-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T10:36:50Z","timestamp":1724755010000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpalliatcare.biomedcentral.com\/articles\/10.1186\/s12904-021-00744-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["744"],"URL":"https:\/\/doi.org\/10.1186\/s12904-021-00744-z","relation":{},"ISSN":["1472-684X"],"issn-type":[{"value":"1472-684X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,1]]},"assertion":[{"value":"16 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Research Ethics and Ethics Committee at Calvary Health Care Bethlehem approved this case report on the 10\/11\/20.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s father, her next-of-kin and medical treatment decision maker, for publication of this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}